Positron Emission Tomography as a Surrogate Marker for Evaluation of Treatment Response in Patients with Desmoid Tumors under Therapy with Imatinib

We used 2-deoxy-2-[(18)F] fluoro-D-glucose (FDG) positron emission tomography (PET) to evaluate patients with desmoid tumors undergoing therapy with imatinib. The study included 22 patients with progressive disease (PD) of a biopsy proven desmoid tumor treated orally with imatinib 800 mg daily. Pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasper, Bernd, Dimitrakopoulou-Strauss, Antonia, Pilz, Lothar R., Strauss, Ludwig G., Sachpekidis, Christos, Hohenberger, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671300/
https://www.ncbi.nlm.nih.gov/pubmed/23762842
http://dx.doi.org/10.1155/2013/389672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671300/
https://www.ncbi.nlm.nih.gov/pubmed/23762842
http://dx.doi.org/10.1155/2013/389672

Ejemplares similares